NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of NewcelX Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NewcelX Ltd. market cap is $31M.
What is the 52-week high for NewcelX Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NewcelX Ltd. 52 week high is $47.40 as of November 01, 2025.
What is the 52-week low for NewcelX Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NewcelX Ltd. 52 week low is $4.20 as of November 01, 2025.
What is NewcelX Ltd. stock price today?
NewcelX Ltd. stock price today is $7.29.
What was NewcelX Ltd. stock price yesterday?
NewcelX Ltd. stock price yesterday was $7.62.
What is the PE ratio of NewcelX Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NewcelX Ltd.’s P/E ratio is -4.20.
What is the Price-to-Book ratio of NewcelX Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NewcelX Ltd. P/B ratio is 10.7391.
What is the 50-day moving average of NewcelX Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NewcelX Ltd. 50-day moving average is $18.71.